Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT04661943
What this trial is testing

Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Ou Bai, MD/PHD 30
Testing effectiveness (Phase 2)Looking for participantsNCT02693535
What this trial is testing

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
American Society of Clinical Oncology 4,200
Testing effectiveness (Phase 2)Ended earlyNCT02282358
What this trial is testing

Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Who this might be right for
LymphomaRelapsed and RefractoryDiffuse Large B-Cell Lymphoma and Follicular Lymphoma
Memorial Sloan Kettering Cancer Center 7
Not applicableNo Longer AvailableNCT03914885
What this trial is testing

Compassionate Use Re-Infusion of ATLCAR.CD30

Who this might be right for
Hodgkin Lymphoma, Adult
UNC Lineberger Comprehensive Cancer Center
Not applicableNo Longer AvailableNCT01196208
What this trial is testing

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001

Who this might be right for
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin+1 more
Seagen Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Not applicableActive Not RecruitingNCT03656835
What this trial is testing

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Germinal Center B-Cell TypeDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+1 more
Ohio State University Comprehensive Cancer Center 73
Large-scale testing (Phase 3)Looking for participantsNCT07300514
What this trial is testing

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

Who this might be right for
Maintenance Treatment of Peripheral T-cell Lymphoma
Fudan University 136
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Not applicableStudy completedNCT01487031
What this trial is testing

Music Therapy on Nausea and Pain for Autologous Stem Cell

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Lymphoma
Case Comprehensive Cancer Center 108
Early research (Phase 1)Looking for participantsNCT04260022
What this trial is testing

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Who this might be right for
Leukemia, Myeloid, ChronicMyeloid LeukemiaChronic Myeloid Leukemia+2 more
Ascentage Pharma Group Inc. 242
Early research (Phase 1)Study completedNCT05024045
What this trial is testing

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, B-cell Marginal ZoneLymphoma, Non-Hodgkin+4 more
Eli Lilly and Company 27
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00140595
What this trial is testing

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

Who this might be right for
Diffuse Large-Cell Lymphoma
Lymphoma Study Association 380
Testing effectiveness (Phase 2)Study completedNCT05978739
What this trial is testing

Evaluating Different Doses of Orelabrutinib in MCL

Who this might be right for
Mantle Cell Lymphoma
InnoCare Pharma Inc. 40
Early research (Phase 1)Looking for participantsNCT07225439
What this trial is testing

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Non Hodgkin LymphomaB-cell Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma+7 more
Paolo Caimi, MD 15
Testing effectiveness (Phase 2)Ended earlyNCT06018129
What this trial is testing

A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNon-Hodgkin Lymphoma
Genmab 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04984837
What this trial is testing

Study of Lacutamab in Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapse/Recurrence
The Lymphoma Academic Research Organisation 49
Not applicableNot Yet RecruitingNCT07764601
What this trial is testing

R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System LymphomaDiffuse Large B-Cell Lymphoma
WEI XU 58
Next Page